Vicadrostat for hypertension

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Jul 2025: Trial registered, NCT07064473
  2. 22 Jul 2025: Trial started, NCT07064473

The trials

NCT07064473: EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

State
Under way
Phase
Phase 3
People
11,800 planned
Started
22 Jul 2025
Primary completion
14 Dec 2029
Arms
Vicadrostat + empagliflozin treatment arm
Results
None posted
  1. 14 Jul 2025: Trial registered
  2. 22 Jul 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.